Prevent Blindness Offers Free Educational Resources on AMD and Low Vision Including Patient and Expert Videos, Webpages, Fact Sheets and More -- CHICAGO , Jan. 27, 2026 /PRNewswire/ -- Prevent ...

Companies across the globe are diligently working toward developing novel Dry Age Macular Degeneration treatment therapies ...

Eyestem Research Pvt Ltd, a biotechnology company developing advanced scalable cell therapy solutions for blindness caused by dry age-related macular degeneration, has received ...

PulseSight Therapeutics SAS, an ophthalmology clinical stage biotech company developing disruptive vectorized gene therapies with minimally-invasive delivery technology, is pleased to announce the ...

Age-related macular degeneration (AMD) once meant a slow, irreversible loss of vision, and many people still believe that's ...

Around a third of people over the age of 80 suffer from age-related macular degeneration (AMD), with an estimated 20 million Americans aged 40 and older currently living with AMD. Most cases are the ...

PulseSight Therapeutics completes patient enrolment in phase I trial of PST-611 to treat dry AMD/geographic atrophy: Paris, France Friday, January 23, 2026, 18:00 Hrs [IST] PulseS ...

An early study testing the effects of a stem cell implant has found that the device is safe and helped some patients see better ...

The evidence evaluating the effect of cataract surgery on the chances people with dry age-related macular degeneration (AMD) will convert to the more severe wet form of the condition has been uneven ...

Ahead of her 91st birthday on Tuesday, Dame Judi Dench has opened up about her worsening eyesight. The beloved actress was first diagnosed with age-related macular degeneration (AMD) in 2012, and ...